We are a team of passionate scientists, doctors and clinicians, driven to bringing promising therapies to light.
ABOUT ANVIRON
About our company, our mission and our team.
OUR PIPELINE
Overview of our pipeline and our science
LATEST NEWS
Latest news releases and investor packages
We are a growing team of scientists, clinicians, and physicians focused on developing promising therapies for difficult to treat diseases. Join a team that is committed to discovering and providing good medicines that make a difference in peoples lives.
JOIN OUR TEAM
COMMUNICATIONS
Get regular updates on our company and pipeline
OUR DRUG PIPELINE
Our pipeline consists of two promising orphan disease therapies that have demonstrated effectivity in vitro and in vivo.
ANV120 for
Inflammation & Autoimmune
A potent stimulator of Fc specific natural regulatory T-Cells resulting in a promising non-steroidal, non-immunosuppresive therapy to treat inflammatory and autoimmune conditions
ANV221 for Pancreatic Cancer
A novel DPAGT-1 inhibitor shown to be superior over existing therapies at reducing pancreatic cancer tumor size and metastases in vivo models.